Details
Stereochemistry | ACHIRAL |
Molecular Formula | C2H3N3 |
Molecular Weight | 69.0653 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
N1C=NC=N1
InChI
InChIKey=NSPMIYGKQJPBQR-UHFFFAOYSA-N
InChI=1S/C2H3N3/c1-3-2-5-4-1/h1-2H,(H,3,4,5)
Molecular Formula | C2H3N3 |
Molecular Weight | 69.0653 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Polynucleating open-chain systems with imidazole and proton-ionizable 1,2,4-triazole structural motifs. | 2001 Apr 6 |
|
Synthesis and in-vitro antimicrobial activity of new 1,2,4-triazoles. | 2001 Feb |
|
Novel synthesis of seco type of acyclo C-nucleosides of 1,2,4-triazole and 1,2,4-triazol. | 2001 Jan-Feb |
|
A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase. | 2001 Mar 1 |
|
Traceless solid-phase synthesis of 1,2,4-triazoles using a novel amine resin. | 2001 Oct 18 |
|
Routes to regioselective deuteriation of heteroaromatic compounds. | 2002 Aug 12 |
|
Liquid chromatographic determination of ampicillin residues in porcine muscle tissue by a multipenicillin analytical method: European Collaborative Study. | 2002 Jul-Aug |
|
A cis amide bond surrogate incorporating 1,2,4-triazole. | 2002 May 17 |
|
Synthesis and properties of new substituted 1,2,4-triazoles: potential antitumor agents. | 2003 Apr 17 |
|
Synthesis of some functionalized arylaminomethyl-1 ,2,4-triazoles, 1,3,4-oxa- and thiadiazoles. | 2003 Nov |
|
Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives. | 2004 Apr |
|
Synthesis of 5-(2-,3- and 4-methoxyphenyl)-4H-1,2,4-triazole-3-thiol derivatives exhibiting anti-inflammatory activity. | 2004 Apr |
|
Synthesis and SAR evaluation of 1,2,4-triazoles as A(2A) receptor antagonists. | 2004 Feb 9 |
|
Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1h-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motif. | 2004 May 20 |
|
Synthesis and potential antimycotic activity of 4-substituted-3-(thiophene-2-yl-methyl)-Delta2-1,2,4-triazoline-5-thiones. | 2004 Sep |
|
Double-headed acyclo C-nucleoside analogues. Functionalized 1,2-bis-(1,2,4-triazol-3-yl)ethane-1,2-diol. | 2005 |
|
Three 1,2,4-triazole derivatives containing substituted benzyl and benzylamino groups. | 2005 Feb |
|
Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety. | 2005 Jan 17 |
|
Energetic azolium azolate salts. | 2005 Jul 11 |
|
Phthalazine PDE IV inhibitors: conformational study of some 6-methoxy-1,4-disubstituted derivatives. | 2005 Jul 15 |
|
Optimized block-wise variable combination by particle swarm optimization for partial least squares modeling in quantitative structure-activity relationship studies. | 2005 Mar-Apr |
|
Synthesis of cyclopentenyl carbocyclic nucleosides as potential antiviral agents against orthopoxviruses and SARS. | 2006 Feb 9 |
|
Discovery of novel triazole-based opioid receptor antagonists. | 2006 Jul 13 |
|
Three-dimensional networks of lanthanide 1,2,4-triazolates: infinity(3)[Yb(Tz)3] and [Eu2(Tz)5(TzH)2], the first 4f networks with complete nitrogen coordination. | 2006 May 21 |
|
Synthesis and light-emitting properties of bipolar oligofluorenes containing triarylamine and 1,2,4-triazole moieties. | 2006 Sep 14 |
|
In situ solvothermal generation of 1,2,4-triazolates and related compounds from organonitrile and hydrazine hydrate: a mechanism study. | 2007 Feb 19 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:32:27 UTC 2023
by
admin
on
Fri Dec 15 17:32:27 UTC 2023
|
Record UNII |
10MS0Y1RDI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EPA PESTICIDE CODE |
600074
Created by
admin on Fri Dec 15 17:32:27 UTC 2023 , Edited by admin on Fri Dec 15 17:32:27 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9257
Created by
admin on Fri Dec 15 17:32:27 UTC 2023 , Edited by admin on Fri Dec 15 17:32:27 UTC 2023
|
PRIMARY | |||
|
83128
Created by
admin on Fri Dec 15 17:32:27 UTC 2023 , Edited by admin on Fri Dec 15 17:32:27 UTC 2023
|
PRIMARY | |||
|
m11036
Created by
admin on Fri Dec 15 17:32:27 UTC 2023 , Edited by admin on Fri Dec 15 17:32:27 UTC 2023
|
PRIMARY | Merck Index | ||
|
DB03594
Created by
admin on Fri Dec 15 17:32:27 UTC 2023 , Edited by admin on Fri Dec 15 17:32:27 UTC 2023
|
PRIMARY | |||
|
35550
Created by
admin on Fri Dec 15 17:32:27 UTC 2023 , Edited by admin on Fri Dec 15 17:32:27 UTC 2023
|
PRIMARY | |||
|
1,2,4-Triazole
Created by
admin on Fri Dec 15 17:32:27 UTC 2023 , Edited by admin on Fri Dec 15 17:32:27 UTC 2023
|
PRIMARY | |||
|
10MS0Y1RDI
Created by
admin on Fri Dec 15 17:32:27 UTC 2023 , Edited by admin on Fri Dec 15 17:32:27 UTC 2023
|
PRIMARY | |||
|
206-022-9
Created by
admin on Fri Dec 15 17:32:27 UTC 2023 , Edited by admin on Fri Dec 15 17:32:27 UTC 2023
|
PRIMARY | |||
|
7860
Created by
admin on Fri Dec 15 17:32:27 UTC 2023 , Edited by admin on Fri Dec 15 17:32:27 UTC 2023
|
PRIMARY | |||
|
288-88-0
Created by
admin on Fri Dec 15 17:32:27 UTC 2023 , Edited by admin on Fri Dec 15 17:32:27 UTC 2023
|
PRIMARY | |||
|
DTXSID6027131
Created by
admin on Fri Dec 15 17:32:27 UTC 2023 , Edited by admin on Fri Dec 15 17:32:27 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
|
||
|
PARENT -> METABOLITE |
lacks pharmacologic activity
MAJOR
|